濮阳惠成(300481) - 2023 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2023 was CNY 349,510,603.42, a decrease of 6.97% compared to CNY 375,712,739.36 in the same period last year[4] - Net profit attributable to shareholders was CNY 70,267,520.49, down 16.23% from CNY 83,882,795.27 year-on-year[4] - The net profit after deducting non-recurring gains and losses was CNY 60,993,614.91, reflecting a decline of 24.03% compared to CNY 80,282,568.76 in the previous year[4] - The company reported a net profit margin of approximately 19.5% for Q1 2023, down from 22.5% in the same quarter last year[17] - The company's net profit for Q1 2023 was CNY 70,247,739.54, a decrease of 16.3% compared to CNY 83,861,960.49 in Q1 2022[18] - The total operating profit for Q1 2023 was CNY 80,043,291.90, down 19.0% from CNY 98,752,503.86 in the same period last year[18] - The company achieved a basic and diluted earnings per share of CNY 0.24, down from CNY 0.28 in Q1 2022[19] - Total comprehensive income for Q1 2023 was CNY 70,247,739.54, a decrease of 16.3% from CNY 83,861,960.49 in Q1 2022[19] Cash Flow and Liquidity - The company reported a significant increase in cash flow from operating activities, amounting to CNY 49,615,520.00, which is up 28.26% from CNY 38,683,619.01 in the same quarter last year[4] - Cash and cash equivalents at the end of Q1 2023 amounted to CNY 398,159,589.53, an increase from CNY 289,241,151.37 at the beginning of the year, representing a growth of 37.7%[14] - The company reported a net cash flow from operating activities of CNY 49,615,520.00, an increase of 28.4% compared to CNY 38,683,619.01 in Q1 2022[22] - Cash and cash equivalents at the end of Q1 2023 totaled CNY 392,158,589.53, down from CNY 588,555,680.68 at the end of Q1 2022[22] Assets and Liabilities - Total assets at the end of Q1 2023 reached CNY 2,966,439,954.50, representing a growth of 5.77% from CNY 2,804,541,794.26 at the end of the previous year[4] - Total assets as of March 31, 2023, were CNY 2,966,439,954.50, up from CNY 2,804,541,794.26, marking an increase of 5.8%[16] - Total liabilities increased to CNY 574,753,989.70 from CNY 484,715,812.81, which is an increase of 18.6%[16] - Shareholders' equity totaled CNY 2,391,685,964.80, up from CNY 2,319,825,981.45, reflecting a growth of 3.1%[16] - Short-term borrowings rose to CNY 270,135,208.33 from CNY 150,135,208.33, an increase of 79.9%[16] Operating Costs and Expenses - Total operating costs for Q1 2023 were CNY 281,491,165.18, slightly up from CNY 280,965,738.18 in the previous year[17] - The company's financial expenses surged by 301.40% to CNY 2,753,608.58, mainly due to increased interest expenses and exchange losses[9] - The company's financial expenses increased significantly to CNY 2,753,608.58, compared to CNY 686,003.52 in Q1 2022[18] - Research and development expenses decreased to CNY 17,395,116.03, down 26.2% from CNY 23,563,792.74 in Q1 2022[18] Sales and Investment - The company experienced a 25% increase in the sales volume of phthalic anhydride derivatives, despite a decline in product prices due to raw material costs[7] - Investment income rose by 147.52% to CNY 7,255,082.51, attributed to higher returns from financial investments[9] - Investment activities resulted in a net cash outflow of CNY 57,024,319.03, compared to a net inflow of CNY 306,427,923.11 in the previous year[22]